Larvae of a new malaria mosquito species are abundantly present in water containers in cities in Ethiopia. The mosquito, Anopheles stephensi, is the main malaria mosquito in India but only appeared on the African continent a few years ago. It has now been found in cities and towns in urban settings in Ethiopia, Sudan, and Djibouti. Researchers from the Radboud university medical center and the Armauer Hansen Research Institute in Ethiopia showed that the invading mosquito species is highly susceptible to local malaria strains. Malaria can therefore become an increasing problem for urban areas in Ethiopia and elsewhere in Africa.
In Africa, malaria has traditionally been a rural disease, with towns and cities associated with much lower levels or absence of malaria. This is due to the fact that most African malaria mosquitoes breed in rural areas. However, the introduction of Anopheles stephensi may increase the malaria risk for urban populations. Over recent years there have been increasing reports of the Asian mosquito species Anopheles stephensi in the Horn of Africa. Anopheles stephensi can reproduce particularly well in human-made containers with clean water. This makes Anopheles stephensi a notorious mosquito species for urban malaria.
The Asian mosquito appears to be particularly susceptible to African malaria
A mosquito species only poses a health risk if it can spread local malaria parasites. “That is why we performed mosquito feeding experiments with the blood of Ethiopian malaria patients. This allowed us to determine whether the local malaria parasite can develop in the new mosquito,” explains Professor of Epidemiology of Tropical Infectious Diseases Teun Bousema, theme Infectious diseases and global health. “To our surprise, the Asian mosquito turned out to be even more susceptible to local malaria parasites than our Ethiopian mosquito colony. This mosquito appears to be an extremely efficient spreader of the two main species of malaria”.
With this important puzzle piece, concerns about urban malaria in Africa are increasing. In 2019, the World Health Organization (WHO) already sounded the alarm about the possible consequences of the invasion of Anopheles stephensi in Africa. With these new findings, these concerns seem justified. “An aggressive approach to target this mosquito is now a top priority,” concludes Fitsum Tadesse. “Only if we act quickly can we prevent the spread to other urban areas on the continent. We must target the mosquito larvae in places where they now occur and prevent mosquitoes from spreading over long distances, for example via airports and sea ports. If that fails, the risk of urban malaria will rise in large parts of Africa.”
With approximately 216 million cases and 400,000 deaths per year, malaria is one of the most important infectious diseases of our time. Compared to the situation before the year 2000, there is a clear decrease in the number of sick people, especially in Sub-Saharan Africa and South America. Unfortunately, malaria now seems to be on the rise in several areas where it was previously under control. Plasmodium falciparum and Plasmodium vivax are the main types of malaria for humans. They are transmitted to humans by mosquitoes and vice versa. There are about 60 mosquito species that can transmit human malaria. In Africa, a number of mosquito species are traditionally responsible for the most malaria transmission. Anopheles gambiae mosquitoes have been labeled the most dangerous animal species on earth and are especially common in rural settings in Africa. Spraying with Insecticides and the use of impregnated mosquito netting against mosquitoes are among the most effective ways to combat malaria. Since 2015, a vaccine has been registered for use. This vaccine, Mosquirix, offers some protection against Plasmodium falciparum malaria, the deadliest form of malaria. Preventing the spread of malaria is considered one of the greatest challenges in the fight against malaria.
Publication in Emerging Infectious Diseases Anopheles stephensi Mosquitoes as Vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019
Related news items
KNAW Early Career Award for Martine Hoogman2 December 2021
Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.read more
T-Guard can reset immune system1 December 2021
For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.read more
Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI1 December 2021
Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.read more
Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab1 December 2021
Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro.read more
Participating in cancer research among people with intellectual disabilities30 November 2021
Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer.read more
Dutch-Nordic Alliance for Precision Cancer Medicine launched26 November 2021
The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.read more